Aortic and arterial manifestations and clinical features inTGFB3-related heritable thoracic aortic disease: results from the Montalcino Aortic Consortium
- 9 December 2024
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 62 (2) , 82-88
Abstract
Background: Pathogenic variants inTGFB3may lead to a syndromic genetic aortopathy. Heritable thoracic aortic disease (HTAD) and arterial events may occur inTGFB3-related disease but there are limited outcomes data on vascular events in this condition.Methods: Clinical data, phenotypical features and aortic outcomes in individuals with pathogenic/likely pathogenic (P/LP)TGFB3variants enrolled in the Montalcino Aortic Consortium registry were reviewed.Results: 34 individuals (56% male, median age 42 years, IQR 17–49, range 3–74 years) with P/LPTGFB3variants were studied. Craniofacial, cutaneous and musculoskeletal features seen in Loeys-Dietz syndrome were variably present. Extra-aortic cardiovascular features included arterial tortuosity (25%), extra-aortic arterial aneurysms (6%) and mitral valve prolapse (21%).Aortic dilation (Z-Score>2) was present in 10 individuals (29%) and aortic dissection occurred in 2 (6%). Type A aortic dissection occurred in two patients (aged between 55 years and 60 years), and one of these patients experienced a type B aortic dissection 6 years later. Seven adults (median age 62 years, range 32–69 years) with aortic root dilation (41–49 mm) are being followed. No patients have undergone prophylactic aortic surgery. Twenty-five per cent of children have aortic dilation. Sixty-eight per cent of the entire cohort remains free of aortic disease. No deaths have occurred.Conclusions: TGFB3-related HTAD is characterised by late-onset and less penetrant thoracic aortic and arterial disease compared with other transforming growth factor β HTAD. Based on our data, a larger aortic size threshold for prophylactic aortic surgery is appropriate in patients withTGFB3-related HTAD compared with HTAD due toTGFBR1orTGFBR2variants.Keywords
Funding Information
- Temerty Family Foundation
- NIH (NIH R01HL109942)
- Pam and Ron Rubin Fund at Washington University in St Louis School of Medicine
- Neidorff Aortopathy and Master Clinician in Cardiology Fellowship Program at Washington University in St Louis School of Medicine
- Genetic Aortic Disorders Association Canada
This publication has 27 references indexed in Scilit:
- Nonsense-Mediated mRNA Decay in Human Health and Diseases: Current Understanding, Regulatory Mechanisms and Future PerspectivesMolecular Biotechnology, 2024
- Comparative Risks of Initial Aortic Events Associated With Genetic Thoracic Aortic DiseaseJACC, 2022
- Exome sequencing identifies a novel heterozygous TGFB3 mutation in a disorder overlapping with Marfan and Loeys-Dietz syndromeMolecular and Cellular Probes, 2015
- Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and DissectionsJACC, 2015
- The Risk for Type B Aortic Dissection in Marfan SyndromeJACC, 2015
- De novo mutation of the latency‐associated peptide domain of TGFB3 in a patient with overgrowth and Loeys–Dietz syndrome featuresAmerican Journal of Medical Genetics Part A, 2014
- A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with marfan and loeys–dietz syndromeAmerican Journal of Medical Genetics Part A, 2013
- Normal Limits in Relation to Age, Body Size and Gender of Two-Dimensional Echocardiographic Aortic Root Dimensions in Persons ≥15 Years of AgeThe American Journal of Cardiology, 2012
- Aggressive Cardiovascular Phenotype of Aneurysms-Osteoarthritis Syndrome Caused by Pathogenic SMAD3 VariantsJACC, 2012
- Nomograms for Aortic Root Diameters in Children Using Two-Dimensional EchocardiographyThe American Journal of Cardiology, 2010